Karen Akinsanya
Director/Board Member chez NAUTILUS BIOTECHNOLOGY, INC.
Fortune : - $ au 31/03/2024
Profil
Karen Akinsanya is the founder of Envision Science Group LLC, which was founded in 2007.
She holds the title of President at Envision Science Group LLC.
Dr. Akinsanya's current jobs include being an Independent Director at Nautilus Biotechnology, Inc. since 2022, a Trustee at The Rockefeller University, and the President-Research & Development Therapeutics at Schrödinger, Inc. since 2018.
Dr. Akinsanya's former job was as a Vice President at Merck & Co., Inc. from 2013 to 2017.
She received her undergraduate degree from Queen Mary University of London and her doctorate from Royal Postgraduate Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SCHRODINGER, INC.
-.--% | 04/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Karen Akinsanya
| Sociétés | Poste | Début |
|---|---|---|
| SCHRÖDINGER, INC. | Corporate Officer/Principal | 01/04/2018 |
| NAUTILUS BIOTECHNOLOGY, INC. | Director/Board Member | 30/03/2022 |
| Envision Science Group LLC | Founder | 01/01/2007 |
| The Rockefeller University | Director/Board Member | - |
Anciens postes connus de Karen Akinsanya
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01/07/2017 |
Formation de Karen Akinsanya
| Queen Mary University of London | Undergraduate Degree |
| Royal Postgraduate Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SCHRÖDINGER, INC. | Technology Services |
| NAUTILUS BIOTECHNOLOGY, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Envision Science Group LLC |
